Tag: medicine

Nearly four months after Syros Pharmaceuticals licensed a drug from a company in Japan, it’s secured $40 million to move the drug into mid-stage trials. The funding adds to $83 million raised in the last two years, and was led…

Laguna Hills-based Hallux, an investigational-stage pharmaceutical company focused on developing a new dosage form and route of administration for treating onychomycosis, announced the completion of Series A financing of $7.1 million. Deerfield Management led the round. Hallux is developing an…

Orig3n, Inc., a Boston, MA-based biotechnology company developing treatments for rare and genetically inherited diseases, closed a $12.5m Series A financing. The round was co-led by Hatteras Venture Partners and Syno Capital with participation from new investor DEFTA Partners and…

Louisville, KY-based care management company Edumedics has raised $4.2 million in Series A financing led by Lunsford Capital. The round was joined by Chicago-based OCA Ventures and syndicate of angel investors and seed funds. Among them: Entrepreneur and Chrysalis Ventures…

AltheaDx Inc., a leading personalized medicine company, today announced it has raised $30 million in Series C financing led by WuXi Healthcare Ventures. Among the firms joining WXHV are new investors WuXi PharmaTech, Ally Bridge Group and ALMA Life Sciences.…